AGIO
Agios Pharmaceuticals, Inc.Company with tickers: AGIO
CIK
1439222
CUSIP
00847X104
Shares Outstanding
59,471,609
Website
https://www.agios.com
13F Activity (30d)
16 filings
2 filers
Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-13 | Agios Investor Event at EHA 2026 (Virtual) | Event |
| 2026-06-01 | Agios Expands into ITP with Global License Agreement for Next-Generation SYK Inhibitor Cevidoplenib | Event |
| 2026-05-19 | RBC Capital Markets 2026 Global Healthcare Conference (Fireside Chat) | Conference |
| 2026-05-12 | Bank of America Securities 2026 Global Healthcare Conference (Fireside Chat) | Conference |
| 2026-04-29 | Q1 2026 Agios Financial Results and Business Highlights | Event |
| 2026-03-02 | 46th Annual TD Cowen Healthcare Conference Fireside | Conference |
| 2026-02-12 | Q4 and FY 2025 Agios Financial Results and Business Highlights | Event |
| 2026-01-14 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-12-24 | AQVESME™ (mitapivat) FDA Approval | Event |
| 2025-11-19 | Topline results Phase 3 RISE UP in Sickle Cell Disease | Event |